论文信息 - Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial - 字舞流文

Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial

B. Entenmann | A. Liekfeld | J. Schrecker | A. Asadi | R. Guthoff | N. Feltgen | H. Höh | F. Kretz | C. Foja | J. Wachtlin | K. Engelmann | Bernd Schade | U. Kretschmann | A. Mohr | R. Khaireddin | J. Wrede | P. F. Zeitz | R. Leaback | A. Shirlaw | Pankaj Singh | Andrea Neugebauer | A. Gross | H. Dave | C. Schuart | B. Padge | N. Eter | A. Schumacher | Ali Elisabeth Peyman Erik Andreas K. Hita Tushar Ahmed Asadi Bator-Banasik Bayati Beeke Cordes Dave | Elisabeth Bator-Banasik | P. Bayati | E. Beeke | A. Cordes | Ahmed Elshinnawi | U. Reinking | D. Schell | Peyman Bayati

[1] Gerard Reid,et al. OBSERVED COMPLICATIONS FROM DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF MACULAR EDEMA IN RETINAL VEIN OCCLUSION OVER 3 TREATMENT ROUNDS , 2015, Retina.

[2] C. Sigouin,et al. Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study , 2015, Clinical ophthalmology.

[3] D. Papaconstantinou,et al. Safety and efficacy of dexamethasone intravitreal implant (Ozurdex) for the treatment of persistent macular edema secondary to retinal vein occlusion in eyes previously treated with anti-vascular endothelial growth factors. , 2015, Current Drug Safety.

[4] D. Roth,et al. Two or more dexamethasone intravitreal implants as monotherapy or in combination therapy for macular edema in retinal vein occlusion: subgroup analysis of a retrospective chart review study , 2015, BMC Ophthalmology.

[5] M. Varano,et al. Prospective Evaluation of Morphological and Functional Changes after Repeated Intravitreal Dexamethasone Implant (Ozurdex®) for Retinal Vein Occlusion , 2015, Ophthalmic Research.

[6] L. Kodjikian,et al. Anatomical and functional recurrence after dexamethasone intravitreal implants: a 6-month prospective study , 2015, Eye.

[7] C. Chiquet,et al. Intravitreal dexamethasone implant versus anti-VEGF injection for treatment-naïve patients with retinal vein occlusion and macular edema: a 12-month follow-up study , 2015, Graefe's Archive for Clinical and Experimental Ophthalmology.

[8] R. Adelman,et al. Strategy for the Management of Macular Edema in Retinal Vein Occlusion: The European VitreoRetinal Society Macular Edema Study , 2015, BioMed research international.

[9] F. Holz,et al. Retrospective, Observational Study in Patients Receiving a Dexamethasone Intravitreal Implant 0.7 mg for Macular Oedema Secondary to Retinal Vein Occlusion , 2014, Ophthalmologica.

[10] P. Lanzetta,et al. Early Effects of Dexamethasone Implant on Macular Morphology and Visual Function in Patients with Macular Edema Secondary to Retinal Vein Occlusion , 2014, Ophthalmologica.

[11] J. Haller,et al. ONSET AND DURATION OF VISUAL ACUITY IMPROVEMENT AFTER DEXAMETHASONE INTRAVITREAL IMPLANT IN EYES WITH MACULAR EDEMA DUE TO RETINAL VEIN OCCLUSION , 2014, Retina.

[12] G. Coscas. Author Reply To: Retreatment with Ozurdex for Macular Edema Secondary to Retinal Vein Occlusion , 2014, European journal of ophthalmology.

[13] D. Roth,et al. EFFICACY AND SAFETY OF TWO OR MORE DEXAMETHASONE INTRAVITREAL IMPLANT INJECTIONS FOR TREATMENT OF MACULAR EDEMA RELATED TO RETINAL VEIN OCCLUSION (SHASTA STUDY) , 2014, Retina.

[14] R. Mathew,et al. Monthly OCT monitoring of Ozurdex for macular oedema related to retinal vascular diseases: re-treatment strategy (OCTOME Report 1) , 2014, Eye.

[15] G. Soubrane,et al. Retreatment with Ozurdex for Macular Edema Secondary to Retinal Vein Occlusion , 2014, European journal of ophthalmology.

[16] R. Mathew,et al. Monthly OCT monitoring of Ozurdex for macular oedema related to retinal vascular diseases: re-treatment strategy (OCTOME Report 1) , 2014, Eye.

[17] Mathias Maier,et al. Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6‐month follow‐up – The SOLO study , 2013, Acta ophthalmologica.

[18] G. Querques,et al. Repeated Intravitreal Dexamethasone Implant (Ozurdex®) for Retinal Vein Occlusion , 2012, Ophthalmologica.

[19] P. Mitchell,et al. Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant. , 2012, Ophthalmology.

[20] M. Blumenkranz,et al. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. , 2011, Ophthalmology.

[21] S. Whitcup,et al. Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. , 2010, Investigative ophthalmology & visual science.

[22] P. Wiedemann,et al. Retinal vein thrombosis: pathogenesis and management , 2010, Journal of thrombosis and haemostasis : JTH.

[23] P. Rosenfeld,et al. NOVEL METHOD FOR ANALYZING SNELLEN VISUAL ACUITY MEASUREMENTS , 2010, Retina.

[24] M. Blumenkranz,et al. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. , 2010, Ophthalmology.

[25] G. Coscas. [Retinal vein occlusions]. , 1983, La Revue du praticien.